Hunan Fangsheng Pharmaceutical Co., Ltd.

SHSE:603998 Stok Raporu

Piyasa değeri: CN¥5.3b

Hunan Fangsheng Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Hunan Fangsheng Pharmaceutical is forecast to grow earnings and revenue by 16.5% and 15.5% per annum respectively. EPS is expected to grow by 16.1% per annum. Return on equity is forecast to be 17% in 3 years.

Anahtar bilgiler

16.5%

Kazanç büyüme oranı

16.1%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi19.3%
Gelir büyüme oranı15.5%
Gelecekteki özkaynak getirisi17.0%
Analist kapsamı

Low

Son güncelleme31 Aug 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet

Jun 06
The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet

Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders

Apr 30
Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders

Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up

Mar 04
Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) 34% Share Price Surge Not Quite Adding Up

Kazanç ve Gelir Büyüme Tahminleri

SHSE:603998 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20262,478369N/A5134
12/31/20252,144299N/A3284
12/31/20241,834243N/A3084
9/30/20241,762273104216N/A
6/30/20241,68421739209N/A
3/31/20241,630193-7198N/A
12/31/20231,629187-13188N/A
9/30/20231,649168-67163N/A
6/30/20231,774329-25171N/A
3/31/20231,80631512198N/A
12/31/20221,792286130302N/A
9/30/20221,81226788279N/A
6/30/20221,7109148244N/A
3/31/20221,6538131218N/A
12/31/20211,567701186N/A
9/30/20211,46666-55125N/A
6/30/20211,42568-2191N/A
3/31/20211,3516857235N/A
12/31/20201,2796469237N/A
9/30/20201,1996945196N/A
6/30/20201,13463-10128N/A
3/31/20201,11975-28149N/A
12/31/20191,09479-37163N/A
9/30/20191,07383-29150N/A
6/30/20191,0788145195N/A
3/31/20191,0417455154N/A
12/31/20181,05173101176N/A
9/30/20181,00045134187N/A
6/30/201891960N/A116N/A
3/31/201883765N/A65N/A
12/31/201772160N/A17N/A
9/30/201770688N/A46N/A
6/30/201763478N/A79N/A
3/31/201756772N/A111N/A
12/31/201653470N/A119N/A
9/30/201647075N/A86N/A
6/30/201645781N/A76N/A
3/31/201646486N/A87N/A
12/31/201546991N/A91N/A
9/30/201546091N/A85N/A
6/30/201544586N/A99N/A
3/31/201544689N/A129N/A
12/31/201441681N/A94N/A
12/31/201340073N/A123N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 603998's forecast earnings growth (16.5% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 603998's earnings (16.5% per year) are forecast to grow slower than the CN market (25.7% per year).

Yüksek Büyüme Kazançları: 603998's earnings are forecast to grow, but not significantly.

Gelir ve Pazar: 603998's revenue (15.5% per year) is forecast to grow faster than the CN market (14.1% per year).

Yüksek Büyüme Geliri: 603998's revenue (15.5% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 603998's Return on Equity is forecast to be low in 3 years time (17%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y